Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers
Stopped The good progress of the Italian national vaccination campaign against COVID-19 made impossible to complete the study as planned.
Conditions
- COVID-19
- Protection Against COVID-19 and Infections With SARS-CoV- 2
- COVID-19 Immunisation
Interventions
- BIOLOGICAL: COVID-eVax
- DEVICE: Cliniporator® and EPSGun
Sponsor
Takis
Collaborators